JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 125 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 6.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,000 | -33.3% | 2,358 | -59.7% | 0.00% | – |
| Q4 2022 | $6,000 | +500.0% | 5,852 | +1040.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 513 | +116.5% | 0.00% | – |
| Q2 2022 | $1,000 | -93.8% | 237 | -89.8% | 0.00% | – |
| Q1 2022 | $16,000 | -72.4% | 2,325 | -66.1% | 0.00% | – |
| Q4 2021 | $58,000 | +70.6% | 6,865 | +51.4% | 0.00% | – |
| Q3 2021 | $34,000 | +100.0% | 4,533 | +77.2% | 0.00% | – |
| Q2 2021 | $17,000 | -26.1% | 2,558 | +12.0% | 0.00% | – |
| Q1 2021 | $23,000 | +228.6% | 2,283 | +133.2% | 0.00% | – |
| Q4 2020 | $7,000 | +250.0% | 979 | +226.3% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | -80.0% | 300 | -86.0% | 0.00% | – |
| Q1 2020 | $10,000 | -16.7% | 2,149 | +59.9% | 0.00% | – |
| Q4 2019 | $12,000 | +1100.0% | 1,344 | +348.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -75.0% | 300 | -51.3% | 0.00% | – |
| Q3 2018 | $4,000 | -33.3% | 616 | -25.0% | 0.00% | – |
| Q2 2018 | $6,000 | -85.0% | 821 | -54.4% | 0.00% | – |
| Q1 2018 | $40,000 | +700.0% | 1,800 | +418.7% | 0.00% | – |
| Q4 2017 | $5,000 | -76.2% | 347 | -74.0% | 0.00% | – |
| Q3 2017 | $21,000 | +2000.0% | 1,337 | +1571.2% | 0.00% | – |
| Q2 2017 | $1,000 | -88.9% | 80 | -80.0% | 0.00% | – |
| Q1 2017 | $9,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 662,063 | $10,315,000 | 30.07% |
| Omega Fund Management, LLC | 579,650 | $9,031,000 | 5.11% |
| Casdin Capital, LLC | 399,825 | $6,229,000 | 1.76% |
| Cormorant Asset Management, LP | 359,738 | $5,605,000 | 0.99% |
| Foresite Capital Management II, LLC | 119,912 | $1,868,000 | 0.76% |
| Redmile Group, LLC | 955,598 | $14,888,000 | 0.73% |
| PFM Health Sciences, LP | 1,727,997 | $26,922,000 | 0.53% |
| Fosun International Ltd | 285,960 | $4,455,000 | 0.44% |
| Partner Investment Management, L.P. | 14,265 | $222,000 | 0.21% |
| Spark Investment Management LLC | 162,200 | $2,527,000 | 0.14% |